A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
CRAB Alert: The EVS Role in Preventing Infection
Why Hospital Waiting Rooms Aren't Going Away
Ground Broken on Mount Sinai Tisch Cancer Hospital
Design, Compartmentation, Training: How Defend-in-Place Strategies Can Protect Patients
Milestone Marked with Topping Out Ceremony for BayCare Hospital Manatee